Advanced

Bradykinin B1 receptor up-regulation by interleukin-1β and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts

Phagoo, Stephen B; Reddi, Krisanavane; Anderson, Kathryn D.; Leeb-Lundberg, Fredrik LU and Warburton, David (2001) In Journal of Pharmacology and Experimental Therapeutics 298(1). p.77-85
Abstract

Bradykinin B1 receptors (B1R) are rapidly induced after tissue trauma and are thought to be involved in maintaining the inflammatory response. Little is known about the intracellular signaling pathways mediating B1R induction in response to stress and inflammation. Here, we show that up-regulation of B1R by B1R agonist and interleukin-1β (IL-1β) occur through distinct but synergistic pathways in IMR-90 human lung fibroblasts. Incubation of cells with the B1R agonist desArg10kallidin (desArg10KD; 100 nM) and IL-1β (500 pg/ml) resulted in a 3- and 4-fold increase, respectively, in B1R by 6 h, whereas coincubation of these factors produced up to a 20-fold increase. Furthermore, coincubation increased the potency of... (More)

Bradykinin B1 receptors (B1R) are rapidly induced after tissue trauma and are thought to be involved in maintaining the inflammatory response. Little is known about the intracellular signaling pathways mediating B1R induction in response to stress and inflammation. Here, we show that up-regulation of B1R by B1R agonist and interleukin-1β (IL-1β) occur through distinct but synergistic pathways in IMR-90 human lung fibroblasts. Incubation of cells with the B1R agonist desArg10kallidin (desArg10KD; 100 nM) and IL-1β (500 pg/ml) resulted in a 3- and 4-fold increase, respectively, in B1R by 6 h, whereas coincubation of these factors produced up to a 20-fold increase. Furthermore, coincubation increased the potency of IL-1β by 2-fold. Both the individual and the synergistic responses were sensitive to genistein, a general tyrosine kinase inhibitor. On the other hand, only the desArg10KD response and the synergistic response were sensitive to the p38 mitogen-activated protein kinase inhibitor SB 203580. Furthermore, only the synergistic response was sensitive to the nuclear factor-κB inhibitor pyrrolidine dithiocarbamate. Despite B1R up-regulation in A549 human lung epithelial cells by desArg10KD or IL-1β individually, these factors did not act synergistically in this cell line. In conclusion, our results reinforce the view that kinins act in concert with proinflammatory cytokines to enhance selectively the inflammatory response of certain lung cells to kinins through distinct but synergistic intracellular signaling mechanisms. Thus, kinins may exert a pivotal role in maintaining and modulating feed-forward inflammatory processes in the lung.

(Less)
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
in
Journal of Pharmacology and Experimental Therapeutics
volume
298
issue
1
pages
77 - 85
publisher
American Society for Pharmacology and Experimental Therapeutics
external identifiers
  • scopus:0034971271
ISSN
0022-3565
language
English
LU publication?
no
id
fe34fe85-34ac-4752-aa1f-6712f78092ad
alternative location
http://jpet.aspetjournals.org/content/298/1/77/tab-article-info
date added to LUP
2017-04-07 09:12:52
date last changed
2018-05-29 10:52:04
@article{fe34fe85-34ac-4752-aa1f-6712f78092ad,
  abstract     = {<p>Bradykinin B1 receptors (B1R) are rapidly induced after tissue trauma and are thought to be involved in maintaining the inflammatory response. Little is known about the intracellular signaling pathways mediating B1R induction in response to stress and inflammation. Here, we show that up-regulation of B1R by B1R agonist and interleukin-1β (IL-1β) occur through distinct but synergistic pathways in IMR-90 human lung fibroblasts. Incubation of cells with the B1R agonist desArg<sup>10</sup>kallidin (desArg<sup>10</sup>KD; 100 nM) and IL-1β (500 pg/ml) resulted in a 3- and 4-fold increase, respectively, in B1R by 6 h, whereas coincubation of these factors produced up to a 20-fold increase. Furthermore, coincubation increased the potency of IL-1β by 2-fold. Both the individual and the synergistic responses were sensitive to genistein, a general tyrosine kinase inhibitor. On the other hand, only the desArg<sup>10</sup>KD response and the synergistic response were sensitive to the p38 mitogen-activated protein kinase inhibitor SB 203580. Furthermore, only the synergistic response was sensitive to the nuclear factor-κB inhibitor pyrrolidine dithiocarbamate. Despite B1R up-regulation in A549 human lung epithelial cells by desArg<sup>10</sup>KD or IL-1β individually, these factors did not act synergistically in this cell line. In conclusion, our results reinforce the view that kinins act in concert with proinflammatory cytokines to enhance selectively the inflammatory response of certain lung cells to kinins through distinct but synergistic intracellular signaling mechanisms. Thus, kinins may exert a pivotal role in maintaining and modulating feed-forward inflammatory processes in the lung.</p>},
  author       = {Phagoo, Stephen B and Reddi, Krisanavane and Anderson, Kathryn D. and Leeb-Lundberg, Fredrik and Warburton, David},
  issn         = {0022-3565},
  language     = {eng},
  number       = {1},
  pages        = {77--85},
  publisher    = {American Society for Pharmacology and Experimental Therapeutics},
  series       = {Journal of Pharmacology and Experimental Therapeutics},
  title        = {Bradykinin B1 receptor up-regulation by interleukin-1β and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts},
  volume       = {298},
  year         = {2001},
}